Title: Promising Results from ORSERDU® Combination Studies in ER+, HER2- Metastatic Breast Cancer Patients Presented at the 2023 San Antonio...
Prostate cancer is one of the most common types of cancer that affects men worldwide. According to the American Cancer...
Title: Promising Phase III Data Revealed for Novel Telomerase Inhibitor Imetelstat Introduction: In the field of cancer research, the development...
Everest Medicines, a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products for patients in Greater China and other...
Zetomipzomib’s Investigational New Drug Application Accepted in China, Announces Everest Medicines Everest Medicines, a biopharmaceutical company focused on developing and...
The Food and Drug Administration (FDA) has recently granted priority review to the combination of Keytruda (pembrolizumab) and Padcev (enfortumab...
Newly Developed Molecular Therapy Shows Promise in Treating Drug-Resistant Biliary Tract Cancer Biliary tract cancer, also known as cholangiocarcinoma, is...
Bladder cancer is a type of cancer that affects the cells lining the bladder, a hollow organ in the pelvis...
The U.S. Food and Drug Administration (FDA) has recently granted approval for a new treatment option for adults with desmoid...
The Effects of mTOR Inhibition on Cell Senescence and Cellular Function in Human Cardiac Progenitor Cells: Insights from the STAT3-PIM1...
The European Commission has recently approved a groundbreaking initial treatment for ovarian cancer, providing hope for thousands of women across...
The European Union (EU) has recently approved the use of BRUKINSA (zanubrutinib) as a treatment option for patients with follicular...
Oxurion, a biopharmaceutical company specializing in the development of innovative treatments for retinal diseases, recently presented key findings from the...
The Food and Drug Administration (FDA) has recently granted approval for the use of Xtandi (enzalutamide) in the treatment of...
Positive Results Obtained from Trial of Novel CGRP Migraine Medicine Migraine is a debilitating neurological disorder that affects millions of...
